The Maybach Journal: Memory Pharmaceuticals Reports First Quarter 2008 Financial Results

tmcnet.com     May 14, 2008            

MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how to consistently profit from whatever the markets throw our way should sign up to www.maybachfinancial.com for a free trial... [read full story]                    

FULL COVERAGE

Memory Pharmaceuticals to Host R&D Day on May 16, 2008

prnewswire.com     May 12, 2008          

MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY), today announced that it will host an R&D Day for the investment community on Friday, May 16, 2008 in New York City. Presentations will begin at 9:00 a.m. EDT and will focus on...                    

comments

Memory Pharmaceuticals Reports First Quarter 2008 Financial Results

prnewswire.com     May 14, 2008          

MONTVALE, N.J., May 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today reported its financial results for the first quarter ended March 31, 2008. In May, Roche exercised its option to license R3487/MEM 3454, Memory Pharmaceuticals' lead nicotinic alpha-7 receptor...                    

comments